Agilon Health AGL Institutional Ownership

Updated Oct 11, 2026

agilon health, inc. (NYSE:AGL) was held by 178 institutional investors that filed 13F reports for the quarter ended June 30, 2026.

• Collectively, these holders controlled 96.45% of Agilon Health's outstanding shares in Q2 2026, up from 3.73% in Q1 2026.
• The number of Agilon Health holders fell 11.44% compared with Q2 2025.
• Of the 178 holders of AGL in Q2 2026, 176 added to their positions and 2 reduced their stakes.
• Altogether, institutional holders owned 16.19Mn AGL shares at the end of Q2 2026, up 15.57Mn from the prior quarter and up 2.4Mn from a year earlier.
• Clayton, Dubilier & Rice, LLC held the largest position in AGL at 4Mn shares as of June 30, 2026, or 23.83% of shares outstanding.
• Among existing holders, the largest additions to Agilon Health in Q2 2026 came from Clayton, Dubilier & Rice, LLC (+3.84Mn shares), Morgan Stanley (+1.93Mn shares), North Peak Capital Management, LLC (+1.42Mn shares), BlackRock, Inc. (+1.11Mn shares) and AQR Capital Management LLC (+653.55K shares).
• The biggest cuts to AGL positions during Q2 2026 came from Dimensional Fund Advisors LP (-3.17K shares) and Osaic Holdings, Inc. (-12 shares).
• Agilon Health's 10 largest institutional shareholders as of Q2 2026 were Clayton, Dubilier & Rice, LLC (4Mn shares), Morgan Stanley (2.01Mn shares), North Peak Capital Management, LLC (1.49Mn shares), BlackRock, Inc. (1.15Mn shares), AQR Capital Management LLC (692.54K shares), Goldman Sachs Group Inc (686.79K shares), Vanguard Capital Management LLC (525.33K shares), Marshall Wace, LLP (468.29K shares), Durable Capital Partners LP (440.64K shares) and D. E. Shaw & Co., Inc. (390.15K shares), per Business Quant data.